Emerging Infectious Diseases and Antimicrobial Resistance (EIDAR)
Abstract
The Infectious Disease Clinical Research Program’s (IDCRP) Emerging Infectious Diseases and Antimicrobial Resistance (EIDAR) Research Area is a Department of Defense (DoD) clinical research capability that is responsive and adaptive to emerging infectious disease (EID) threats to US military readiness. Among active-duty and other Military Health System (MHS) beneficiaries, EIDAR research is largely focused on evaluating the incidence, risk factors, and acute- and long-term health effects of military-relevant EIDs, especially those caused by high-consequence pathogens or are responsible for outbreaks among US military populations. The EIDAR efforts also address Force Health Protection concerns associated with antimicrobial resistance and antimicrobial stewardship practices within the MHS.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 20, 2019
- Source ID
- 10.1093/milmed/usz081
Entities
People
- Charlotte Lanteri
- Katrin Mende
- Mark Kortepeter
Organizations
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Uniformed Services University of the Health Sciences
- United States Department of Defense
- University of Nebraska–Lincoln